2022 Fall Conference | C2 - Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Date Friday 10/28/22

Time 08:00 AM - 09:30 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Srikanth Muppidi, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should become familiar with the developments in the diagnosis of autoimmune Myasthenia Gravis, currently available therapeutics, and potential new therapies in the pipeline with novel mechanisms of action.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Didactic

Program Materials

Event Timeline
08:00 AM - 08:05 AM PDT	Introduction	Myasthenia Gravis Srikanth Muppidi, MD, FAAN
08:05 AM - 08:45 AM PDT	Speaker	Myasthenia Gravis and Traditional Therapies Shaida Khan, DO
08:45 AM - 09:25 AM PDT	Speaker	Myasthenia Gravis and Newer Therapies (Complement and FcRN) Srikanth Muppidi, MD, FAAN
09:25 AM - 09:30 AM PDT	Q&A	Questions and Answers Srikanth Muppidi, MD, FAAN, Shaida Khan, DO

Faculty Disclosures
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Shaida Khan, DO	Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chamblee Ryan .